CLINICAL_TRIALS
research
· 2026-04-14
Clinical Trial Update: Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Summary
This clinical trial update describes a screening protocol from NIAID to identify genetic diseases of lymphocyte homeostasis and programmed cell death in individ…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Primary Immune Deficiency | Status: RECRUITING